Nuo Therapeutics (AURX, $1.54) was one of top quarterly gainers, jumping to $1.54 per share. A.I.dvisor analyzed 836 stocks in the Biotechnology Industry over the last three months, and discovered that of them (2) charted an Uptrend while of them (7) trended down. A.I.dvisor found 144 similar cases when AURX's price jumped over within three months. In out of those 144 cases, AURX's price went up during the following month. Based on these historical data, A.I. thinks the odds of an Uptrend continuation for AURX are